Skip to content

Computed Tomography Perfusion Colorectal Cancer With Tumor Grade

Computed Tomography Perfusion of Colorectal Cancer in Correlation With Tumor Grade

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03448302
Enrollment
50
Registered
2018-02-28
Start date
2018-03-10
Completion date
2019-07-10
Last updated
2018-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colo-rectal Cancer

Brief summary

Colorectal cancer is the third most commonly diagnosed cancer in the world. The 5-years survival rate depends on the tumor stage and grade at patient presentation. Individual treatment strategy based on the tumor stage and grade should be applied to improve the prognosis, So the pre-operative diagnostic evaluation and grading of colorectal cancer are important.

Detailed description

Diagnosis of cancer colon is usually based on colonoscopy which provides direct visualization of the lesions and allows for biopsies. However the pre-operative specimens from endoscopic biopsies sometimes fail to grade tumor because of the lack of sufficient tissue. Recent improvements in computed tomography have allowed for minimally invasive evaluation of cancer colon. Quantitative iodine density measurement can be used to differentiate low and high grade colorectal cancer. However, debate continues regarding the correlation between tumor grade and computed tomography perfusion parameters of colorectal cancer demonstrating the need for further investigation in this area of research.

Interventions

Pre-contrast images will be obtained to identify the colorectal tumor location. Then Fifty milliliters of iopromide (Ultravist ) will be injected intra-venously at rate of 5 milliliter per second via an automatic pump injector for computed tomography perfusion scans. Computed tomography perfusion scans will be performed at the mid-portion of the tumor for 60seconds beginning 5 seconds after contrast injection. Then arterial input will be defined by using the mouse to place a circular region of interest and the tumor region of interest will be placed on the most enhanced area of the tumor. Tumor blood flow, blood volume, mean transient time & permeability surface measurements will be obtained.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Any patient with primary colorectal mass

Exclusion criteria

* Colorectal mass pathologically proved to be benign Female patient at child bearing period with suspected pregnancy Raised renal chemistry Hypersensitivity to contrast.

Design outcomes

Primary

MeasureTime frameDescription
Blood flow of tumorOne monthAccuracy of blood flow of the tumor in prediction of tumor grade in correlation with histopathological results

Secondary

MeasureTime frameDescription
Blood volume of the tumorOne monthAccuracy of blood volume of the tumor in prediction of tumor grade in correlation with histopathological results
Mean transient time of the tumorOne monthtransient time of the tumor in prediction of tumor grade in correlation with histopathological results
Permeability surface of the tumorOne monthAccuracy of permeability surface of the tumor in prediction of tumor grade in correlation with histopathological results

Countries

Egypt

Contacts

Primary ContactAfaf A Hassan, MD
Drafaf.kader@yahoo.com01095229303
Backup ContactMostafa A El-Sharkawy, MD
drmostafamri@yahoo.com01223971443

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026